From July 1, 2022 to August 7, 2022, the company has repurchased 1,992,600 shares, representing 0.12% for CNY 20.05 million. With this, the company has completed the repurchase of 4,187,406 shares, representing 0.26% for CNY 40.05 million under the buyback announced on February 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.29 CNY | +1.20% | -0.85% | -9.10% |
Apr. 25 | Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 28 | Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.10% | 2.15B | |
-0.28% | 90.59B | |
-0.92% | 38.99B | |
-9.57% | 34.09B | |
-17.98% | 15.02B | |
-6.74% | 13.17B | |
-9.76% | 11.88B | |
-47.31% | 10.65B | |
+6.82% | 9.25B | |
+137.06% | 9.02B |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.